• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Complementary medicine in uro-oncology
Urologe A. 2021 Jun 15. doi: 10.1007/s00120-021-01584-8. Online ahead of print.ABSTRACTComplementary and alternative medicine (CAM) is widespread in oncology patients with a user rate of approximately 40-50%. An accompanying supportive effect can arise through improved adherence, especially in long-term (e.g. endocrine) therapies through active patient involvement. When assessing the evidence on frequently requested methods, there is no high-quality evidence that homeopathy or anthroposophy leads to an improved prognosis. Mistletoe therapy can be considered to improve the quality of life, although the data quality is weak....
Source: Der Urologe. Ausg. A - June 15, 2021 Category: Urology & Nephrology Authors: Jutta H übner Ralph M ücke Oliver Micke Christian Keinki Source Type: research

Importance of complementary medicine approaches for patients with prostate cancer.
CONCLUSION: The results show that prostate cancer patients use a range of CM and have a need for information about CM. Prostate cancer patients are in a special situation because of a regular feedback on the prostate-specific antigen (PSA) value. This should be taken into consideration in consultation with prostate cancer patients regarding CM. PMID: 25297489 [PubMed - as supplied by publisher]
Source: Der Urologe. Ausg. A - October 10, 2014 Category: Urology & Nephrology Authors: Gschwendtner KM, Klein G, Güthlin C, Holmberg C, Horneber M, Weis J Tags: Urologe A Source Type: research